Variants in PDE11A and PDE1A are not associated with citalopram response [3]

Molecular Psychiatry

Volumn 12, Issue 12, 2007, Pages 1061-1063

  Teranishi, K S ^a   Slager, S L ^b   Garriock, H ^a   Kraft, J B ^a   Peters, E J ^a   Reinalda, M S ^b   Jenkins, G D ^b   McGrath, P J ^c   Hamilton, S P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; PHOSPHODIESTERASE I;

CLINICAL TRIAL; ETHNICITY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR DEPRESSION; PHENOTYPE; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ALLELES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; DEPRESSION; FEMALE; GENE FREQUENCY; HUMANS; MALE; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 36549071114     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4002074     Document Type: Letter

References (4)

1. Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM et al. Proc Natl Acad Sci USA 2006; 103: 15124-15129.
2. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA et al. Controlled Clin Trials 2004; 25: 119-142.
3. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al. Am J Psychiatry 2006; 163: 28-40.
4. Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ et al. Biol Psychiatry 2007; 61: 734-742.